title: Combination therapy to prevent cardiovascular disease: slow progress.
authors.affiliation: UnitedHealth Chronic Disease Initiative, London, United Kingdom.
authors.forename: Richard
authors.initials: R
authors.lastname: Smith
authors.forename: Tara
authors.initials: T
authors.lastname: McCready
authors.forename: Salim
authors.initials: S
authors.lastname: Yusuf
mesh_terms: D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001241:Aspirin / Q000008:administration & dosage*; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000517:prevention & control*; D003363:Cost Control; D004338:Drug Combinations; D016527:Drug Costs; D004345:Drug Industry; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D008403:Mass Screening; D055118:Medication Adherence; D010975:Platelet Aggregation Inhibitors; D010818:Practice Patterns, Physicians'; D011322:Primary Prevention; D055502:Secondary Prevention; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin